← back to search

Lifang Liu

Donghua University · CN
Area of research
Molecular Biology · Complementary and alternative medicine
Research interest
Research interests include Traditional Chinese Medicine Analysis, Natural product bioactivities and synthesis, Metabolomics and Mass Spectrometry Studies, and Ginseng Biological Effects and Applications.
h-index
34
citations
3,966
works
253
NIH funding
primary concept
email

Recent publications

Nanocellulose hydrogels with tunable porosity, high elongation, and autonomous healing for promote wound repair
Advanced Composites and Hybrid Materials 2026cited by 1position: lastdoi
Free fatty acids may regulate the expression of 11β-hydroxysteroid dehydrogenase type 1 in the liver of high-fat diet golden hamsters through the ERS-CHOP-C/EBPα signaling pathway
Lipids in Health and Disease 2025cited by 2position: middledoi
ROASMI: accelerating small molecule identification by repurposing retention data
Journal of Cheminformatics 2025cited by 1position: middledoi
Relationship of postprandial fibroblast growth factor 21 with lipids, inflammation and metabolic dysfunction-associated fatty liver disease during oral fat tolerance test
Frontiers in Endocrinology 2024cited by 7position: middledoi
FNICM: A New Methodology To Identify Core Metabolites Based on Significantly Perturbed Metabolic Subnetworks
Analytical Chemistry 2024cited by 4position: middledoi
Serum Fibroblast Growth Factor 21 Level After an Oral Fat Tolerance Test is Related to Postprandial Free Fatty Acid Level
Diabetes Metabolic Syndrome and Obesity 2023cited by 6position: middledoi
Novel insights into stress-induced susceptibility to influenza: corticosterone impacts interferon-β responses by Mfn2-mediated ubiquitin degradation of MAVS
Signal Transduction and Targeted Therapy 2020cited by 31position: middledoi
Epigoitrin, an Alkaloid From Isatis indigotica, Reduces H1N1 Infection in Stress-Induced Susceptible Model in vivo and in vitro
Frontiers in Pharmacology 2019cited by 83position: middledoi
Cancer survivorship: an integral part of Europe's research agenda
Molecular Oncology 2018cited by 151position: middledoi
Signaling Scaffold Protein IQGAP1 Interacts with Microtubule Plus-end Tracking Protein SKAP and Links Dynamic Microtubule Plus-end to Steer Cell Migration
Journal of Biological Chemistry 2015cited by 34position: middledoi
DDA3 associates with microtubule plus ends and orchestrates microtubule dynamics and directional cell migration
Scientific Reports 2013cited by 26position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xiaolong Li · Hebei Medical University3 papers (2023–2025)Kunjie Zheng · Harrison International Peace Hospital3 papers (2023–2025)Xiaoyu Hou · China Pharmaceutical University3 papers (2023–2025) · 2 papers (2023–2024)Zhuo Luo · Guangxi University2 papers (2019–2020)Guangyao Song · Hebei Medical University2 papers (2023–2024)Donald L. Hill · University of Alabama at Birmingham2 papers (2013–2015)Hiroshi Kurihara · Guangzhou University of Chinese Medicine2 papers (2019–2020)Yinghao Yin · Guangzhou University of Chinese Medicine2 papers (2024–2025)Rong‐Rong He · Guangzhou University of Chinese Medicine2 papers (2019–2020)Xuebiao Yao · University of Alabama at Birmingham2 papers (2013–2015)Wei Gu · Hangzhou Center for Disease Control and Prevention2 papers (2023–2024)Chang‐Yu Yan · Guangzhou University of Chinese Medicine2 papers (2019–2020)Gui-Zhong Xin · Nanjing University of Chinese Medicine2 papers (2024–2025)Tingfu Zhang · Hebei Medical University2 papers (2024–2025)Wen Li · Wuhan University2 papers (2019–2020)Dongmei Wang · University of Illinois Chicago2 papers (2013–2015)Peng Xia · Anhui Medical University1 papers (2013–2013)Yilin Hou · Hebei Medical University1 papers (2025–2025)Yi-Fang Li · Union Hospital1 papers (2020–2020)